Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives

Hypertension

Volumn 46, Issue 2, 2005, Pages 273-279

  Wang, Philip S ^a   Avorn, Jerry ^a   Brookhart, M Alan ^a   Mogun, Helen ^a   Schneeweiss, Sebastian ^a   Fischer, Michael A ^a   Glynn, Robert J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Antihypertensive agents; Elderly; Morbidity

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; AGING; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; DEPRESSION; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; GERIATRIC PATIENT; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NURSING HOME; OSTEOARTHRITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ASTHMA; COHORT STUDIES; DEPRESSION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; HYPERTENSION; LUNG DISEASES, OBSTRUCTIVE; MALE; OSTEOARTHRITIS; PATIENT COMPLIANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES;

EID: 23244434856     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000172753.96583.e1     Document Type: Article

References (61)

1. American Heart Association. Heart Disease and Stroke Statistics-2005 Update. Dallas, Tex: American Heart Association: 2005.
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality. Lancet. 2002;360:1903-1913.
3. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure lowering drugs. Lancet. 2000;356:1955-1964.
4. Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension. 2000;35:539-543.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JLJ, Jones DW, Materson BJ, Oparil S, Wright JT, Roccell EJ. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc. 2003;289:2560-2571.
6. Hoffman C, Rice D, Sung HY. Persons with chronic conditions: their prevalence and costs. J Am Med Assoc. 1995;276:1473-1479.
7. Fried LP, Bandeen-Roche K, Kasper JD, Guralnik JM. Association of comorbidity with disability in older women: the Women's Health and Aging Study. J Clin Epidemiol. 1999;52:27-37.
8. Verbrugge LM, Lepkowski JM, Imanaka Y. Comorbidity and its impact on disability. Milbank Q. 1989;67:450-484.
9. Van Den Akker M, Buntinx F, Metsemakers JF, Van Der Aa, Knottnerus JA. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998;51:367-375.
10. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications ol multiple chronic conditions in the elderly. Arch Intern Med. 2002;162:2269-2276.
11. McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Gao X, Borbas C, Gobel F. The effect of comorbidity on use of thrombolysis or aspirin in patients with acute myocardial infarction eligible for treatment. J Gen Intern Med. 1997;12:1-6.
12. Retta TM, Randall OS. Hypertension and concomitant diseases: a guide for evidence-based therapy. J Natl Med Assoc. 2004;96:450-460.
13. Butler RN, August P, Ferdinand KC, Phillips RA, Roccella EJ. Hypertension: how comorbid disease influences the choice of therapy. Part 4 of a roundtable discussion. Geriatrics. 1999;54:34,39-44.
14. Monanc M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997;10:697-704.
15. Docherty A, Dunn FG. Treatment of hypertensive patients with coexisting coronary arterial disease. Curr Opin Cardiol. 2003;18:268-271.
16. Lteif AA, Mather KJ, Clark CM. Diabetes and heart disease an evidence-driven guide to risk factors management in diabetes. Cardiol Rev. 2003; 11:262-274.
17. Blackshenr JL, Schwartz GL. Step care therapy for hypertension in diabetic patients. Mayo Clin Proc. 2001;76:1266-1274.
18. Gambassi G, Lapane K, Sgadari A, Landi F, Carbonin P, Hume A, Lipsitz L, Mor V, Bernabei R. Prevalence, clinical correlates, and treatment of hypertension in elderly nursing home residents. Arch Intern Med. 1998; 158:2377-2385.
19. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516-1520.
20. Steinbrook R. Patients with multiple chronic conditions: how many medications are enough? N Engl J Med. 1998;338:1541-1542.
21. Druss BG, Marcus SC, Olfson M, Pineus HA. The most expensive medical conditions in America. Health Aff (Millwood). 2002;21:105-111.
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
23. Deyo RA, Gherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
24. SAS release 6.12. Cary. NC: SAS Institute: 1996.
25. Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. J Am Med Assoc. 2000;283:506-511.
26. Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Quality of medical care and excess mortality in older patients with mental disorders. Arch Gen Psychiatry. 2001;58:562-572.
27. Desai MM, Rosenheck RA, Druss BG, Perlin JB. Mental disorders and quality of diabetes care in the veterans health administration. Am J Psychiatry. 2002;159:1584-1590.
28. Desai MM, Rosenheck RA, Druss BG, Perlin JB. Receipt of nutrition and exercise counseling among medical outpatients with psychiatric and substance use disorders. J Gen Intern Med. 2002;17:556-560.
29. Stroup-Benham CA, Markides KS, Black SA, Goodwin JS. Relationship between low blood pressure and depressive symptomatology in older people. J Am Geriatr Soc. 2000;48:250-255.
30. Donner-Banzhoff N, Chan Y, Szalai JP, Hilditch JR. Low blood pressure associated with low mood: a red herring? J Clin Epidemiol. 1997;50:1175-1181.
31. Simonsick EM, Wallace RB, Blazer DG. Berkman LF. Depressive symptomatology and hypertension associated with morbidity and mortality in older adults. Psychosom Med. 1995;57:427-435.
32. Chow SL, Luzier AB, DiTusa L, Snyder BD, Izzo JLJ. Acid-suppressive therapy use associated with antihypertensive agents. J Clin Pharmacol. 2001;41:750-756.
33. Gurwitz JH, Avorn J, Bonn RL, Glynn RJ, Monane M, Mogun H. Initiation of antihypertensive treatment during nonsteroidal antiinflammatory drug therapy. J Am Med Assoc. 1994;272:781-786.
34. Solomon DH, Schneeweiss S, Levin R, Avorn J. Relationship between COX-2 specific inhibitors and hypertension. Hypertension. 2004;44:1-6.
35. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 1994;121:289-300.
36. Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Coehrane B, Robbins J, Aragaki A, Dunbar-Jacob J. Depression and cardiovascular sequelae in postmenopausal women: the Women's Health Initiative (WHI). Arch Intern Med. 2004;164:289-298.
37. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC. Cardiovascular morbidity and monality in patients with rheumatoid arthritis. Circulation. 2003;107:1303-1307.
38. Pistelli R, Lange P, Miller DL. Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity. Eur Respir J Suppl. 2003;40:10s-14s.
39. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, Moskowitz MA. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-1963.
40. Hyman DJ, Pavlik VN, Vallbona C. Physician role in lack of awareness and control of hypertension. J Clin Hypertens. 2002;2:324-330.
41. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996;86:1805-1808.
42. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Noncompliance with antihypertensive medications: The impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504-511.
43. Klinkman MS. Competing demands in psychosocial care: a model for the identification and treatment of depressive disorders in primary care. Gen Hosp Psychiatry. 1997;19:98-111.
44. Williams JW. Competing demands: does care for depression fit in primary care? J Gen Intern Med. 1998;13:137-139.
45. Walser BL, Ross-Degnan D, Soumerai SB. Do open formularies increase access to clinically useful drugs? Health Aff (Millwood). 1996;15:95-109.
46. Soumerai SB, Ross-Degnan D. Inadequate prescription-drug coverage for Medicare enrollees: a call to action. N Engl J Med. 1999;340:722-728.
47. Soumerai SB, Ross-Degnan D, Avorn J, McLauglin TJ, Choodnovskiy I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med. 1991;325:1072-1077.
48. Butler RN. Age-ism: another form of bigotry. Gerontologist. 1969;9:243-246.
49. Henderson SO, Bretsky P, DeQuattro V, Henderson BE. Treatment of hypertension in African Americans and Latinos: the effect of JNC VI on urban prescribing practices. J Clin Hypertens. 2003;5:107-112.
50. Ashaye MO, Giles WH. Hypertension in blacks: a literature review. Ethn Dis. 2003;13:456-462.
51. Avorn J, Wang PS. Drug prescribing, adverse reactions, and compliance in elderly patients. In: Salzman C, ed. Clinical Geriatric Psychopharmacology. 4th ed. New York, NY: McGraw-Hill; 2004:23-47.
52. Rovner BW, German PS, Brant LJ, Clark R, Burton L, Folstein MF. Depression and mortality in nursing homes. J Am Med Assoc. 1991;265:993-996.
53. Pear R. Pennsylvania struggles to repair model prescription aid program. New York Times. 7/13/02. Page 1.
54. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia. Pa: Lippincott-Raven; 1998.
55. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drugs to consumers. N Engl J Med. 2002;346:498-505.
56. National High Blood Pressure Education Program: Summary Report. The National High Blood Pressure Education Program Coordinating Committee meeting. Bethesda, Md: National Heart, Lung, and Blood Institute; 2002:1-37. Available at: http://www.nhlbi.nih.gov/about/hhbpep/nhbp_abs.htm.
57. Wang L, Li J. Role of educational intervention in the management of comorbid depression and hypertension. Blood Press. 2003;12:198-202.
58. Friedman RH, Kazis LE, Jette A, Smith MB, Stollerman J, Torgerson J, Carey K. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9:285-292.
59. Singer GM, Izhar M, Black HR. Guidelines for hypertension: are quality-assurance measures on target? Hypertension. 2004;43:198-202.
60. National Committee for Quality Assurance. HEDIS 2000: Technical Specifications. Washington. DC: National Committee for Quality Assurance; 1999:105-110.
61. Tu K, Mamdani MM, Tu JV. Hypertension guidelines in elderly patients: is anybody listening? Am J Med. 2002;113:52-58.